Indeed, 100% of primary ccRCCs were angptl4-positive whereas 93.8% of primary non-ccRCC renal tumors were angptl4-negative (p = 1.5 10−49, Chi-square test). The gene discussed is ANGPTL4; the disease is nonpapillary renal cell carcinoma.